Penem Antibacterial [EPC]

Penem Antibacterial [EPC] was reported 34257 times

Drugs of the Penem Antibacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ANTI FACTOR V ANTIBODY 22 0.7857
1 MENINGITIS CANDIDA 23 0.3286
2 PROTOTHECOSIS 27 0.2872
3 GEOTRICHUM INFECTION 60 0.2844
4 INTRACRANIAL INFECTION 25 0.2000
5 FOETAL ANAEMIA 24 0.1832
6 TRICHOSPORON INFECTION 73 0.1802
7 RHINOCEREBRAL MUCORMYCOSIS 52 0.1499
8 HERPES SIMPLEX OESOPHAGITIS 27 0.1452
9 PERINEPHRIC ABSCESS 20 0.1316
10 DISSEMINATED MUCORMYCOSIS 51 0.1294
11 EMPHYSEMATOUS PYELONEPHRITIS 23 0.1257
12 URINARY TRACT CANDIDIASIS 24 0.1257
13 DYSBIOSIS 102 0.1242
14 ACINETOBACTER INFECTION 135 0.1233
15 AEROMONAS INFECTION 23 0.1217
16 SYSTEMIC CANDIDA 284 0.1130
17 FACTOR V INHIBITION 20 0.1031
18 STENOTROPHOMONAS INFECTION 129 0.0951
19 CONGENITAL MULTIPLEX ARTHROGRYPOSIS 19 0.0931
20 SPINAL MUSCULAR ATROPHY 25 0.0926
21 FUNGAEMIA 144 0.0914
22 CNS VENTRICULITIS 29 0.0890
23 CONDUCTIVE DEAFNESS 28 0.0872
24 FUSARIUM INFECTION 60 0.0857
25 SCEDOSPORIUM INFECTION 58 0.0822
26 CEREBRAL NOCARDIOSIS 19 0.0815
27 FUNGAL ENDOCARDITIS 23 0.0764
28 POSITIVE AIRWAY PRESSURE THERAPY 21 0.0719
29 CANDIDA SEPSIS 64 0.0713
30 SPLENIC ABSCESS 29 0.0713
31 ENTEROCOCCAL INFECTION 337 0.0697
32 SYSTEMIC MYCOSIS 81 0.0693
33 ENTEROCOCCAL SEPSIS 56 0.0691
34 CLOSTRIDIUM TEST POSITIVE 149 0.0675
35 PATHOGEN RESISTANCE 602 0.0660
36 MYCOBACTERIUM ABSCESSUS INFECTION 47 0.0657
37 HYPHAEMA 34 0.0651
38 FUNGAL SEPSIS 54 0.0650
39 PROCALCITONIN INCREASED 76 0.0647
40 INFECTIVE ANEURYSM 32 0.0646
41 VANCOMYCIN INFUSION REACTION 24 0.0637
42 DISSEMINATED ASPERGILLOSIS 30 0.0636
43 ABDOMINAL COMPARTMENT SYNDROME 40 0.0628
44 THROMBOCYTOPENIA NEONATAL 26 0.0618
45 PSEUDOMEMBRANOUS COLITIS 138 0.0617
46 BRAIN ABSCESS 149 0.0588
47 ENTEROCOCCUS TEST POSITIVE 38 0.0586
48 RESPIRATORY TRACT INFECTION BACTERIAL 29 0.0582
49 PYROGLUTAMIC ACIDOSIS 23 0.0579
50 RESPIRATORY GAS EXCHANGE DISORDER 21 0.0566
51 UREAPLASMA INFECTION 23 0.0564
52 MUCORMYCOSIS 146 0.0561
53 BRONCHOPLEURAL FISTULA 21 0.0559
54 PULMONARY NECROSIS 19 0.0557
55 HEPATIC INFARCTION 21 0.0557
56 CARDIAC VALVE VEGETATION 27 0.0556
57 LINEAR IGA DISEASE 92 0.0553
58 PNEUMOCOCCAL SEPSIS 35 0.0533
59 KLEBSIELLA INFECTION 269 0.0531
60 CANDIDA TEST POSITIVE 22 0.0526
61 MEDIASTINITIS 30 0.0517
62 ANAL INFLAMMATION 33 0.0516
63 TUMOUR ASSOCIATED FEVER 21 0.0513
64 KLEBSIELLA BACTERAEMIA 48 0.0505
65 BRONCHOPULMONARY ASPERGILLOSIS 385 0.0496
66 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 20 0.0493
67 PULMONARY MUCORMYCOSIS 26 0.0492
68 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1379 0.0486
69 ENTEROCOCCAL BACTERAEMIA 49 0.0462
70 NOCARDIOSIS 116 0.0453
71 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 23 0.0450
72 HYPERFERRITINAEMIA 19 0.0441
73 CEREBRAL ASPERGILLOSIS 27 0.0439
74 MULTIPLE-DRUG RESISTANCE 136 0.0438
75 PULMONARY NOCARDIOSIS 36 0.0437
76 PNEUMONIA NECROTISING 28 0.0433
77 SARS-COV-2 TEST NEGATIVE 29 0.0430
78 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 35 0.0426
79 ASPERGILLUS INFECTION 278 0.0423
80 SEPSIS SYNDROME 21 0.0418
81 URINARY TRACT INFECTION FUNGAL 23 0.0401
82 PNEUMONIA PSEUDOMONAL 61 0.0397
83 PSEUDOMONAS INFECTION 336 0.0391
84 NEUTROPENIC COLITIS 81 0.0391
85 MOTOR NEURONE DISEASE 19 0.0390
86 EOSINOPHILIC PNEUMONIA ACUTE 33 0.0381
87 TRACHEOBRONCHITIS 29 0.0377
88 PSEUDOMONAL BACTERAEMIA 32 0.0375
89 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 35 0.0370
90 DELAYED GRAFT FUNCTION 26 0.0366
91 STRONGYLOIDIASIS 59 0.0365
92 HAEMOPERITONEUM 29 0.0362
93 URINARY TRACT INFECTION ENTEROCOCCAL 33 0.0353
94 JARISCH-HERXHEIMER REACTION 25 0.0351
95 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 263 0.0350
96 BACILLUS INFECTION 22 0.0348
97 SEPTIC SHOCK 1508 0.0346
98 PNEUMONIA FUNGAL 136 0.0344
99 HYPOFIBRINOGENAEMIA 34 0.0343
100 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 876 0.0340
101 OTOTOXICITY 62 0.0335
102 DRUG RESISTANCE 861 0.0335
103 DISSEMINATED CRYPTOCOCCOSIS 25 0.0330
104 PSEUDOMONAS TEST POSITIVE 27 0.0330
105 LIVER ABSCESS 107 0.0330
106 RASH MORBILLIFORM 91 0.0328
107 ENTEROBACTER INFECTION 55 0.0327
108 ANTICONVULSANT DRUG LEVEL DECREASED 46 0.0326
109 PSEUDOMONAL SEPSIS 57 0.0325
110 VIRAL HAEMORRHAGIC CYSTITIS 23 0.0323
111 DEVICE RELATED SEPSIS 65 0.0323
112 CYTOKINE STORM 22 0.0321
113 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 68 0.0319
114 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 24 0.0319
115 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 120 0.0314
116 PNEUMONIA KLEBSIELLA 57 0.0310
117 TOXIC EPIDERMAL NECROLYSIS 470 0.0309
118 BLOOD FIBRINOGEN DECREASED 35 0.0306
119 CLOSTRIDIUM DIFFICILE COLITIS 325 0.0306
120 HISTIOCYTOSIS HAEMATOPHAGIC 89 0.0299
121 HYPERCHLORAEMIA 19 0.0297
122 METHAEMOGLOBINAEMIA 68 0.0293
123 MENINGITIS BACTERIAL 42 0.0293
124 INFECTION IN AN IMMUNOCOMPROMISED HOST 21 0.0292
125 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 23 0.0292
126 HYPERLACTACIDAEMIA 78 0.0291
127 DIFFERENTIATION SYNDROME 21 0.0286
128 BACTERIAL SEPSIS 92 0.0282
129 GRAFT VERSUS HOST DISEASE IN LIVER 20 0.0279
130 NEPHROGENIC DIABETES INSIPIDUS 32 0.0277
131 PULMONARY CAVITATION 24 0.0276
132 CANDIDA INFECTION 465 0.0275
133 LUNG CONSOLIDATION 77 0.0275
134 CYTOMEGALOVIRUS TEST POSITIVE 49 0.0275
135 ACUTE MYELOID LEUKAEMIA RECURRENT 59 0.0275
136 MEGACOLON 42 0.0267
137 KLEBSIELLA SEPSIS 30 0.0266
138 SEPTIC EMBOLUS 22 0.0264
139 APLASTIC ANAEMIA 137 0.0262
140 WHITE MATTER LESION 33 0.0261
141 EOSINOPHILIA 450 0.0257
142 INFECTIOUS PLEURAL EFFUSION 38 0.0250
143 BRONCHOPULMONARY DYSPLASIA 20 0.0248
144 FEBRILE INFECTION 29 0.0246
145 RENAL ABSCESS 20 0.0244
146 EOSINOPHILIC PNEUMONIA 77 0.0244
147 DISSEMINATED INTRAVASCULAR COAGULATION 344 0.0244
148 ESCHERICHIA BACTERAEMIA 57 0.0242
149 HAEMATOLOGICAL INFECTION 59 0.0241
150 ISCHAEMIC CEREBRAL INFARCTION 28 0.0241
151 BACTERAEMIA 286 0.0241
152 NOSOCOMIAL INFECTION 53 0.0240
153 MIXED LIVER INJURY 71 0.0236
154 SPUTUM INCREASED 51 0.0236
155 THERAPEUTIC PRODUCT CROSS-REACTIVITY 21 0.0235
156 LISTERIOSIS 26 0.0235
157 TYPE IV HYPERSENSITIVITY REACTION 64 0.0233
158 VANISHING BILE DUCT SYNDROME 26 0.0233
159 HYPOPROTEINAEMIA 44 0.0232
160 STAPHYLOCOCCAL BACTERAEMIA 99 0.0228
161 DERMATITIS EXFOLIATIVE GENERALISED 79 0.0227
162 APLASIA 44 0.0224
163 SUBCUTANEOUS EMPHYSEMA 22 0.0224
164 INFLAMMATORY MARKER INCREASED 111 0.0224
165 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 132 0.0223
166 GRAFT VERSUS HOST DISEASE IN SKIN 49 0.0222
167 NECROTISING COLITIS 28 0.0221
168 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 31 0.0219
169 HYPOPERFUSION 23 0.0219
170 ACUTE RESPIRATORY DISTRESS SYNDROME 387 0.0219
171 METABOLIC ALKALOSIS 35 0.0218
172 PNEUMOCYSTIS JIROVECII INFECTION 26 0.0218
173 HYPERLEUKOCYTOSIS 19 0.0214
174 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 162 0.0208
175 HYPOGONADISM 21 0.0208
176 BRAIN HERNIATION 62 0.0207
177 CROSS SENSITIVITY REACTION 20 0.0205
178 ENCEPHALITIS VIRAL 25 0.0205
179 TOXIC ENCEPHALOPATHY 104 0.0205
180 HAEMODYNAMIC INSTABILITY 156 0.0205
181 PNEUMOMEDIASTINUM 37 0.0205
182 ADENOVIRUS INFECTION 59 0.0203
183 HEPATOSPLENOMEGALY 52 0.0202
184 HEPATITIS CHOLESTATIC 122 0.0202
185 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 24 0.0200
186 CEREBRAL PALSY 19 0.0200
187 PULMONARY SEPSIS 29 0.0199
188 ENDOCARDITIS 102 0.0199
189 PNEUMONIA BACTERIAL 182 0.0198
190 OLIGURIA 122 0.0196
191 JOINT CONTRACTURE 21 0.0196
192 HEPATITIS FULMINANT 58 0.0195
193 CHOLESTATIC LIVER INJURY 43 0.0193
194 HYPOALBUMINAEMIA 150 0.0193
195 INFECTION REACTIVATION 22 0.0192
196 HYPERNATRAEMIA 95 0.0190
197 FOLATE DEFICIENCY 22 0.0190
198 CARDIOVASCULAR INSUFFICIENCY 31 0.0190
199 VENOOCCLUSIVE LIVER DISEASE 94 0.0190
200 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 50 0.0188
201 NECROTISING FASCIITIS 65 0.0184
202 HAEMORRHAGIC DISORDER 20 0.0184
203 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 60 0.0181
204 RASH MACULO-PAPULAR 404 0.0181
205 LUNG ABSCESS 38 0.0181
206 COAGULATION TIME PROLONGED 28 0.0181
207 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 50 0.0181
208 CRYPTOCOCCOSIS 29 0.0178
209 NEUTROPENIC SEPSIS 127 0.0178
210 CYTOMEGALOVIRUS VIRAEMIA 79 0.0177
211 ASPERGILLOSIS 23 0.0176
212 EXCESSIVE EYE BLINKING 26 0.0176
213 FEBRILE NEUTROPENIA 1167 0.0176
214 ISCHAEMIC HEPATITIS 24 0.0175
215 OBLITERATIVE BRONCHIOLITIS 23 0.0175
216 DIFFUSE ALVEOLAR DAMAGE 20 0.0174
217 BRONCHIAL DISORDER 27 0.0174
218 MECHANICAL VENTILATION 33 0.0174
219 PULMONARY HAEMORRHAGE 135 0.0172
220 AGRANULOCYTOSIS 320 0.0172
221 RETROPERITONEAL HAEMATOMA 38 0.0172
222 H1N1 INFLUENZA 24 0.0171
223 STAPHYLOCOCCUS TEST POSITIVE 36 0.0171
224 PNEUMONIA CYTOMEGALOVIRAL 33 0.0170
225 STAPHYLOCOCCAL SEPSIS 83 0.0168
226 BICYTOPENIA 32 0.0163
227 RESPIRATORY FAILURE 1185 0.0162
228 ESCHERICHIA INFECTION 133 0.0162
229 ENTEROCOLITIS 93 0.0161
230 VASCULAR PSEUDOANEURYSM 28 0.0161
231 CYTOMEGALOVIRUS INFECTION REACTIVATION 71 0.0161
232 SHOCK HAEMORRHAGIC 130 0.0160
233 HYPERTRANSAMINASAEMIA 111 0.0159
234 INTERVERTEBRAL DISCITIS 30 0.0159
235 TOXIC SKIN ERUPTION 158 0.0157
236 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 78 0.0156
237 INCREASED BRONCHIAL SECRETION 40 0.0156
238 HYPERCAPNIA 47 0.0156
239 HYPERBILIRUBINAEMIA 161 0.0155
240 CYTOKINE RELEASE SYNDROME 311 0.0155
241 TUMOUR LYSIS SYNDROME 136 0.0154
242 PRODUCT DEPOSIT 24 0.0154
243 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 20 0.0152
244 RESUSCITATION 25 0.0151
245 CYTOMEGALOVIRUS INFECTION 250 0.0150
246 CAPILLARY LEAK SYNDROME 31 0.0150
247 COAGULOPATHY 246 0.0147
248 ANURIA 127 0.0147
249 RESPIRATORY ACIDOSIS 58 0.0147
250 CLOSTRIDIUM DIFFICILE INFECTION 322 0.0147
251 HEPATIC CYTOLYSIS 186 0.0146
252 PANCYTOPENIA 811 0.0145
253 ACUTE RESPIRATORY FAILURE 279 0.0145
254 DRUG ERUPTION 257 0.0145
255 CLOSTRIDIAL INFECTION 49 0.0145
256 BLOOD CULTURE POSITIVE 43 0.0143
257 MULTI-ORGAN FAILURE 246 0.0142
258 SUSPECTED OFF LABEL USE 64 0.0142
259 TACHYPNOEA 192 0.0141
260 EMPYEMA 28 0.0141
261 INTRA-ABDOMINAL HAEMORRHAGE 33 0.0138
262 HEPATIC NECROSIS 52 0.0138
263 HYPERAEMIA 27 0.0137
264 EXFOLIATIVE RASH 36 0.0137
265 CYSTITIS HAEMORRHAGIC 55 0.0136
266 ENCEPHALOPATHY 333 0.0135
267 NEPHROPATHY TOXIC 152 0.0135
268 RESPIRATORY ALKALOSIS 22 0.0135
269 PANCREATITIS NECROTISING 31 0.0135
270 GRAFT VERSUS HOST DISEASE 96 0.0133
271 BILIRUBIN CONJUGATED INCREASED 31 0.0133
272 SEPSIS 1465 0.0131
273 COVID-19 PNEUMONIA 154 0.0130
274 ENCEPHALITIS 89 0.0129
275 CHOLESTASIS 247 0.0129
276 ENDOTRACHEAL INTUBATION 36 0.0128
277 TACHYARRHYTHMIA 32 0.0128
278 VENOOCCLUSIVE DISEASE 32 0.0128
279 BK VIRUS INFECTION 43 0.0127
280 EXTREMITY NECROSIS 22 0.0126
281 CYTOMEGALOVIRUS COLITIS 29 0.0126
282 SHOCK 289 0.0126
283 VASCULAR DEVICE INFECTION 57 0.0126
284 RETROPERITONEAL HAEMORRHAGE 31 0.0126
285 HYPERTRIGLYCERIDAEMIA 73 0.0125
286 DRUG LEVEL DECREASED 125 0.0123
287 PNEUMOCYSTIS JIROVECII PNEUMONIA 123 0.0122
288 ACUTE GRAFT VERSUS HOST DISEASE 56 0.0122
289 LEUKOCYTOSIS 221 0.0122
290 WOUND DEHISCENCE 41 0.0121
291 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 66 0.0121
292 BACTERIAL TEST POSITIVE 27 0.0121
293 SYSTEMIC INFECTION 20 0.0121
294 INTESTINAL ISCHAEMIA 66 0.0120
295 HEPATIC FUNCTION ABNORMAL 445 0.0119
296 DISTRIBUTIVE SHOCK 27 0.0119
297 DRUG-INDUCED LIVER INJURY 374 0.0119
298 CEREBELLAR INFARCTION 20 0.0118
299 TRANSPLANT DYSFUNCTION 21 0.0118
300 BRAIN OEDEMA 148 0.0117
301 ACUTE LYMPHOCYTIC LEUKAEMIA 33 0.0116
302 POTENTIATING DRUG INTERACTION 39 0.0116
303 BONE MARROW FAILURE 234 0.0115
304 HYPERAMMONAEMIC ENCEPHALOPATHY 20 0.0115
305 HYPOXIA 405 0.0115
306 SOFT TISSUE INFECTION 21 0.0115
307 BLOOD ALBUMIN DECREASED 91 0.0115
308 CHOLANGITIS 71 0.0114
309 QUADRIPARESIS 19 0.0114
310 ACUTE MYELOID LEUKAEMIA 178 0.0114
311 ESCHERICHIA SEPSIS 33 0.0114
312 MENINGITIS 76 0.0114
313 LUNG INFILTRATION 100 0.0113
314 HEPATORENAL SYNDROME 19 0.0112
315 DEAFNESS NEUROSENSORY 37 0.0112
316 NEUROLOGICAL DECOMPENSATION 26 0.0112
317 PYELONEPHRITIS ACUTE 22 0.0112
318 ACIDOSIS 85 0.0111
319 C-REACTIVE PROTEIN INCREASED 401 0.0110
320 METABOLIC ENCEPHALOPATHY 33 0.0110
321 SKIN NECROSIS 57 0.0110
322 THROMBOTIC MICROANGIOPATHY 107 0.0110
323 THROMBOCYTOPENIA 1222 0.0109
324 HERPES SIMPLEX 71 0.0109
325 DEVICE RELATED INFECTION 168 0.0109
326 SPLENIC INFARCTION 19 0.0109
327 LONG QT SYNDROME 26 0.0108
328 HYDROCEPHALUS 59 0.0108
329 CHEST X-RAY ABNORMAL 33 0.0108
330 GASTROINTESTINAL OEDEMA 19 0.0107
331 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 589 0.0107
332 HEPATOMEGALY 105 0.0107
333 ATELECTASIS 103 0.0106
334 THROMBOCYTOSIS 39 0.0106
335 DERMATITIS EXFOLIATIVE 53 0.0106
336 NEUROTOXICITY 185 0.0105
337 PULSELESS ELECTRICAL ACTIVITY 44 0.0105
338 ELECTROENCEPHALOGRAM ABNORMAL 33 0.0104
339 HYPERPYREXIA 44 0.0104
340 HEPATOTOXICITY 231 0.0104
341 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 99 0.0104
342 PROTEIN TOTAL DECREASED 39 0.0103
343 STEVENS-JOHNSON SYNDROME 230 0.0103
344 DRUG LEVEL INCREASED 171 0.0103
345 ACUTE HEPATIC FAILURE 141 0.0103
346 BACTERIAL INFECTION 192 0.0103
347 GRANULOCYTE COUNT DECREASED 19 0.0102
348 SERUM FERRITIN INCREASED 54 0.0102
349 HYPOVOLAEMIC SHOCK 49 0.0102
350 CARDIAC FAILURE ACUTE 68 0.0102
351 EOSINOPHIL COUNT INCREASED 85 0.0102
352 PNEUMOTHORAX 161 0.0101
353 ELECTROLYTE IMBALANCE 117 0.0101
354 PULMONARY ALVEOLAR HAEMORRHAGE 56 0.0100
355 LOW BIRTH WEIGHT BABY 79 0.0099
356 EPSTEIN-BARR VIRUS INFECTION 62 0.0099
357 FAECES PALE 22 0.0099
358 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 23 0.0099
359 HEPATIC FAILURE 298 0.0099
360 FEBRILE BONE MARROW APLASIA 42 0.0099
361 ESCHERICHIA URINARY TRACT INFECTION 42 0.0099
362 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 32 0.0098
363 TUBULOINTERSTITIAL NEPHRITIS 184 0.0098
364 DERMATITIS BULLOUS 71 0.0098
365 DRUG LEVEL BELOW THERAPEUTIC 54 0.0098
366 DISSEMINATED TUBERCULOSIS 25 0.0097
367 PANCREATITIS CHRONIC 23 0.0097
368 COMPLICATIONS OF TRANSPLANTED KIDNEY 22 0.0097
369 COMA SCALE ABNORMAL 28 0.0097
370 BLOOD LACTATE DEHYDROGENASE INCREASED 153 0.0096
371 HEPATITIS TOXIC 25 0.0096
372 LEUKOPENIA 477 0.0095
373 AMYLASE INCREASED 35 0.0095
374 MYELOSUPPRESSION 339 0.0094
375 BRAIN DEATH 29 0.0094
376 TRANSPLANT FAILURE 23 0.0094
377 PREMATURE DELIVERY 149 0.0093
378 HYPOPHOSPHATAEMIA 69 0.0093
379 CIRCULATORY COLLAPSE 158 0.0093
380 INTRAVENTRICULAR HAEMORRHAGE 23 0.0092
381 HYPERAMMONAEMIA 46 0.0092
382 NECROSIS 51 0.0092
383 CLONUS 25 0.0091
384 ABDOMINAL INFECTION 23 0.0090
385 ILEUS PARALYTIC 40 0.0090
386 ORGAN FAILURE 36 0.0089
387 ACUTE KIDNEY INJURY 1360 0.0089
388 RENAL TUBULAR DISORDER 25 0.0089
389 FUNGAL INFECTION 294 0.0088
390 HEPARIN-INDUCED THROMBOCYTOPENIA 43 0.0087
391 STAPHYLOCOCCAL INFECTION 287 0.0087
392 BLOOD BILIRUBIN INCREASED 235 0.0087
393 ORGANISING PNEUMONIA 43 0.0087
394 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 19 0.0086
395 METABOLIC ACIDOSIS 275 0.0086
396 MUCOSAL INFLAMMATION 225 0.0086
397 CYTOPENIA 105 0.0086
398 PROTHROMBIN TIME PROLONGED 51 0.0085
399 HYPERTHERMIA 65 0.0085
400 JAUNDICE CHOLESTATIC 30 0.0085
401 CUTANEOUS VASCULITIS 31 0.0085
402 OTITIS MEDIA 28 0.0085
403 FIBRIN D DIMER INCREASED 30 0.0084
404 SUBDURAL HAEMORRHAGE 23 0.0084
405 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 22 0.0084
406 PORTAL VEIN THROMBOSIS 27 0.0083
407 POLYNEUROPATHY 100 0.0083
408 TRANSAMINASES INCREASED 185 0.0083
409 IMMUNE THROMBOCYTOPENIA 38 0.0083
410 HYPOKALAEMIA 383 0.0083
411 METABOLIC DISORDER 48 0.0083
412 SERUM SICKNESS 23 0.0082
413 LIVER INJURY 202 0.0082
414 RHINOVIRUS INFECTION 32 0.0082
415 AUTOIMMUNE HAEMOLYTIC ANAEMIA 28 0.0082
416 HAEMOLYSIS 63 0.0082
417 STATUS EPILEPTICUS 92 0.0081
418 GUILLAIN-BARRE SYNDROME 39 0.0081
419 HYPERURICAEMIA 33 0.0080
420 RESPIRATORY DISTRESS 221 0.0080
421 GENERALISED OEDEMA 99 0.0080
422 LUNG OPACITY 21 0.0080
423 ELECTROCARDIOGRAM QT PROLONGED 286 0.0079
424 CARDIOPULMONARY FAILURE 31 0.0079
425 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 40 0.0079
426 MYCOBACTERIUM AVIUM COMPLEX INFECTION 21 0.0078
427 RENAL IMPAIRMENT 651 0.0077
428 MALNUTRITION 86 0.0077
429 LARGE INTESTINE PERFORATION 53 0.0076
430 TRANSPLANT REJECTION 61 0.0076
431 IMMUNOSUPPRESSION 67 0.0076
432 EPILEPSY 232 0.0076
433 MACULE 21 0.0076
434 UPPER GASTROINTESTINAL HAEMORRHAGE 127 0.0075
435 STREPTOCOCCAL INFECTION 42 0.0075
436 GASTROINTESTINAL NECROSIS 22 0.0075
437 RENAL TUBULAR NECROSIS 74 0.0075
438 BLOOD UREA INCREASED 126 0.0075
439 FOETAL DEATH 39 0.0075
440 KIDNEY TRANSPLANT REJECTION 36 0.0075
441 HYPOGAMMAGLOBULINAEMIA 49 0.0075
442 DISEASE COMPLICATION 34 0.0074
443 HEPATOCELLULAR INJURY 105 0.0074
444 OXYGEN SATURATION ABNORMAL 21 0.0074
445 CACHEXIA 38 0.0074
446 CEREBRAL ISCHAEMIA 38 0.0074
447 PETECHIAE 77 0.0074
448 BLOOD ALKALINE PHOSPHATASE INCREASED 183 0.0074
449 GAMMA-GLUTAMYLTRANSFERASE INCREASED 163 0.0073
450 NEUTROPENIA 997 0.0073
451 GENERALISED TONIC-CLONIC SEIZURE 121 0.0073
452 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 37 0.0073
453 ASCITES 214 0.0073
454 OESOPHAGEAL CANDIDIASIS 29 0.0073
455 LEUKOENCEPHALOPATHY 27 0.0072
456 HYPERSENSITIVITY VASCULITIS 19 0.0072
457 CHOLECYSTITIS ACUTE 41 0.0072
458 RALES 42 0.0072
459 CYSTIC FIBROSIS 40 0.0072
460 ORAL CANDIDIASIS 95 0.0072
461 AREFLEXIA 19 0.0071
462 SUBCUTANEOUS ABSCESS 34 0.0071
463 HEPATITIS ACUTE 46 0.0071
464 PANCREATITIS ACUTE 159 0.0071
465 ALANINE AMINOTRANSFERASE INCREASED 434 0.0071
466 HAEMORRHAGIC DIATHESIS 25 0.0070
467 HYPOTONIA 70 0.0070
468 AZOTAEMIA 28 0.0070
469 ACUTE PULMONARY OEDEMA 39 0.0069
470 CARDIAC ARREST 573 0.0069
471 PNEUMONIA ASPIRATION 173 0.0069
472 HAEMOTHORAX 20 0.0069
473 NEPHRITIS 23 0.0069
474 MYOCLONUS 82 0.0069
475 VENTRICULAR HYPOKINESIA 22 0.0068
476 ABDOMINAL ABSCESS 30 0.0068
477 HYPERKALAEMIA 238 0.0068
478 ALTERED STATE OF CONSCIOUSNESS 146 0.0067
479 UROSEPSIS 62 0.0067
480 BRONCHOPNEUMONIA 23 0.0067
481 ODYNOPHAGIA 40 0.0067
482 HAEMORRHAGE INTRACRANIAL 100 0.0067
483 NEUTROPHIL COUNT DECREASED 272 0.0067
484 PLEURAL EFFUSION 406 0.0067
485 PYREXIA 2302 0.0066
486 BLOOD LACTIC ACID INCREASED 35 0.0066
487 CONCOMITANT DISEASE AGGRAVATED 41 0.0066
488 PNEUMONIA VIRAL 21 0.0066
489 LYMPHOPENIA 93 0.0066
490 PERITONITIS 136 0.0066
491 CEREBRAL HAEMATOMA 22 0.0065
492 PARADOXICAL DRUG REACTION 24 0.0065
493 ABSCESS 104 0.0065
494 DELIRIUM 226 0.0065
495 PARTIAL SEIZURES 34 0.0065
496 DRUG INTERACTION 1029 0.0065
497 CANDIDIASIS 26 0.0065
498 ASPARTATE AMINOTRANSFERASE INCREASED 342 0.0064
499 LACTIC ACIDOSIS 207 0.0064
500 PROCTALGIA 41 0.0064
501 ARTHRITIS BACTERIAL 26 0.0063
502 PURULENT DISCHARGE 27 0.0063
503 PULMONARY TUBERCULOSIS 27 0.0063
504 CARDIAC TAMPONADE 30 0.0063
505 URINE OUTPUT DECREASED 55 0.0063
506 THROMBOTIC THROMBOCYTOPENIC PURPURA 22 0.0062
507 STUPOR 20 0.0062
508 SINUS TACHYCARDIA 88 0.0062
509 DRUG LEVEL ABOVE THERAPEUTIC 28 0.0061
510 PURPURA 54 0.0061
511 HEPATITIS 156 0.0061
512 PREMATURE BABY 183 0.0061
513 PYELONEPHRITIS 52 0.0060
514 BLOOD CREATININE INCREASED 391 0.0060
515 DEPRESSED LEVEL OF CONSCIOUSNESS 236 0.0060
516 NEUROLOGICAL SYMPTOM 34 0.0059
517 EMBOLISM 49 0.0059
518 BODY TEMPERATURE INCREASED 120 0.0059
519 DEMYELINATION 24 0.0059
520 CARDIOGENIC SHOCK 84 0.0058
521 EXTRAVASATION 24 0.0058
522 SPLENOMEGALY 68 0.0058
523 THERAPY NON-RESPONDER 260 0.0058
524 BREATH SOUNDS ABNORMAL 28 0.0057
525 OESOPHAGITIS 62 0.0057
526 PLATELET COUNT DECREASED 601 0.0056
527 LYMPHOCYTE COUNT DECREASED 99 0.0056
528 HEPATIC ENCEPHALOPATHY 52 0.0056
529 NEUROLEPTIC MALIGNANT SYNDROME 66 0.0056
530 PYODERMA GANGRENOSUM 20 0.0056
531 ILEUS 69 0.0055
532 HEPATIC LESION 24 0.0055
533 PERICARDIAL EFFUSION 128 0.0055
534 LIVER FUNCTION TEST ABNORMAL 161 0.0055
535 APLASIA PURE RED CELL 19 0.0055
536 VENTRICULAR FIBRILLATION 61 0.0055
537 TORSADE DE POINTES 43 0.0055
538 DIFFUSE LARGE B-CELL LYMPHOMA 42 0.0054
539 FUNGAL SKIN INFECTION 22 0.0054
540 RENAL FAILURE 723 0.0054
541 LOWER GASTROINTESTINAL HAEMORRHAGE 40 0.0054
542 LUNG INFECTION 84 0.0054
543 EJECTION FRACTION DECREASED 84 0.0054
544 BRONCHOSPASM 77 0.0054
545 WHITE BLOOD CELL COUNT INCREASED 207 0.0054
546 NEUTROPHIL COUNT INCREASED 55 0.0054
547 SEROTONIN SYNDROME 103 0.0054
548 PNEUMONITIS 146 0.0054
549 MYOSITIS 48 0.0053
550 ENTERITIS 34 0.0053
551 HAEMOPTYSIS 148 0.0053
552 PLATELET COUNT INCREASED 69 0.0053
553 HYPERVOLAEMIA 26 0.0053
554 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 32 0.0053
555 SUBARACHNOID HAEMORRHAGE 53 0.0052
556 COLITIS ISCHAEMIC 35 0.0052
557 POSTOPERATIVE WOUND INFECTION 35 0.0052
558 HYPOCALCAEMIA 98 0.0052
559 ANAEMIA 986 0.0052
560 PERIPHERAL ISCHAEMIA 21 0.0051
561 HAEMOLYTIC ANAEMIA 46 0.0051
562 MYOPATHY 44 0.0051
563 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 45 0.0051
564 LEFT VENTRICULAR DYSFUNCTION 34 0.0051
565 OCULAR ICTERUS 22 0.0051
566 RESPIRATORY SYNCYTIAL VIRUS INFECTION 44 0.0050
567 RESPIRATORY DISORDER 151 0.0050
568 ANAL ABSCESS 27 0.0050
569 DUODENAL ULCER 35 0.0050
570 RHABDOMYOLYSIS 206 0.0049
571 INTERSTITIAL LUNG DISEASE 239 0.0049
572 ABSCESS LIMB 21 0.0049
573 SUPRAVENTRICULAR TACHYCARDIA 47 0.0049
574 HAEMODIALYSIS 41 0.0049
575 PNEUMONIA 1551 0.0048
576 ISCHAEMIA 22 0.0048
577 DECUBITUS ULCER 39 0.0048
578 GRANULOCYTOPENIA 27 0.0047
579 GASTRITIS EROSIVE 22 0.0047
580 OSTEOMYELITIS 85 0.0047
581 DERMATITIS ALLERGIC 59 0.0047
582 UNRESPONSIVE TO STIMULI 120 0.0046
583 MENTAL STATUS CHANGES 129 0.0046
584 PROTEIN URINE PRESENT 23 0.0046
585 HYPOMAGNESAEMIA 64 0.0046
586 VENTRICULAR TACHYCARDIA 75 0.0045
587 JAUNDICE 122 0.0045
588 ARTHRITIS INFECTIVE 21 0.0045
589 CEREBRAL INFARCTION 110 0.0045
590 DISEASE PROGRESSION 532 0.0045
591 HYPOTENSION 896 0.0045
592 ADRENAL INSUFFICIENCY 54 0.0044
593 MYOCARDITIS 51 0.0044
594 PULMONARY MASS 66 0.0044
595 HEMIPARESIS 75 0.0044
596 CHRONIC LYMPHOCYTIC LEUKAEMIA 21 0.0044
597 CONDITION AGGRAVATED 1341 0.0044
598 TACHYCARDIA 391 0.0044
599 RESPIRATORY RATE INCREASED 39 0.0044
600 TREATMENT FAILURE 362 0.0044
601 BUNDLE BRANCH BLOCK RIGHT 20 0.0044
602 PULMONARY OEDEMA 195 0.0044
603 GLOMERULAR FILTRATION RATE DECREASED 53 0.0043
604 LIVER DISORDER 191 0.0043
605 GINGIVAL SWELLING 19 0.0043
606 ERYTHEMA MULTIFORME 40 0.0043
607 RENAL FAILURE ACUTE 181 0.0043
608 HYPOTHERMIA 43 0.0042
609 INTERNATIONAL NORMALISED RATIO INCREASED 121 0.0042
610 APNOEA 33 0.0042
611 MELAENA 93 0.0042
612 HYPONATRAEMIA 238 0.0042
613 GASTROINTESTINAL TOXICITY 20 0.0042
614 HYDRONEPHROSIS 31 0.0041
615 STILLBIRTH 20 0.0041
616 BLOOD CREATINE PHOSPHOKINASE INCREASED 119 0.0041
617 INTRACRANIAL PRESSURE INCREASED 23 0.0041
618 PAPULE 29 0.0041
619 RESPIRATORY TRACT INFECTION 107 0.0041
620 ACUTE CORONARY SYNDROME 34 0.0041
621 GASTROINTESTINAL HAEMORRHAGE 343 0.0041
622 FACE OEDEMA 69 0.0041
623 HAEMATOMA 105 0.0040
624 FAILURE TO THRIVE 21 0.0040
625 OFF LABEL USE 3521 0.0040
626 GENERAL PHYSICAL HEALTH DETERIORATION 463 0.0040
627 RASH VESICULAR 19 0.0039
628 ASPIRATION 43 0.0039
629 MOTOR DYSFUNCTION 40 0.0039
630 LIPASE INCREASED 30 0.0039
631 NERVOUS SYSTEM DISORDER 122 0.0039
632 COLITIS 148 0.0039
633 INFECTION 564 0.0039
634 BRAIN INJURY 39 0.0039
635 BENIGN PROSTATIC HYPERPLASIA 20 0.0039
636 PULMONARY CONGESTION 51 0.0039
637 NEUTROPHILIA 22 0.0039
638 OXYGEN SATURATION DECREASED 217 0.0039
639 CARDIOTOXICITY 34 0.0038
640 HAEMOGLOBIN DECREASED 391 0.0038
641 CHOLECYSTITIS 45 0.0038
642 HYPOVOLAEMIA 22 0.0038
643 LYMPHOEDEMA 26 0.0038
644 WHITE BLOOD CELL COUNT DECREASED 403 0.0037
645 BRONCHIECTASIS 25 0.0037
646 GASTROENTERITIS 54 0.0037
647 CARDIAC FAILURE 297 0.0037
648 VASCULITIS 43 0.0037
649 INTESTINAL PERFORATION 41 0.0036
650 PRODUCT USE IN UNAPPROVED INDICATION 904 0.0036
651 DRUG INEFFECTIVE 4797 0.0036
652 HAEMATOCRIT DECREASED 71 0.0036
653 RASH PUSTULAR 26 0.0036
654 HYPERCHLORHYDRIA 21 0.0036
655 TROPONIN INCREASED 27 0.0035
656 ORAL DISORDER 26 0.0035
657 OEDEMA 192 0.0035
658 PANCREATITIS 187 0.0035
659 HAEMATURIA 121 0.0035
660 CELLULITIS 178 0.0035
661 CEREBRAL HAEMORRHAGE 126 0.0035
662 CARDIO-RESPIRATORY ARREST 147 0.0035
663 BRADYCARDIA 186 0.0035
664 ECCHYMOSIS 24 0.0035
665 SEIZURE 402 0.0035
666 ATRIAL FIBRILLATION 337 0.0035
667 STRESS CARDIOMYOPATHY 20 0.0034
668 CYANOSIS 54 0.0034
669 HYPERGLYCAEMIA 124 0.0034
670 FACIAL PARALYSIS 29 0.0034
671 EXPOSURE DURING PREGNANCY 210 0.0034
672 RESPIRATORY ARREST 93 0.0034
673 RASH ERYTHEMATOUS 161 0.0034
674 CARDIOMEGALY 41 0.0033
675 MYELODYSPLASTIC SYNDROME 48 0.0033
676 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 34 0.0033
677 RIGHT VENTRICULAR FAILURE 23 0.0033
678 TENDERNESS 34 0.0033
679 PULMONARY TOXICITY 23 0.0032
680 PERIPHERAL SENSORY NEUROPATHY 19 0.0032
681 SCOLIOSIS 20 0.0032
682 HEPATIC ENZYME INCREASED 220 0.0032
683 COMA 153 0.0032
684 PLEURISY 19 0.0032
685 ABNORMAL FAECES 26 0.0032
686 LYMPHADENOPATHY 112 0.0032
687 TRANSFUSION 33 0.0031
688 FOETAL GROWTH RESTRICTION 19 0.0031
689 NEPHROPATHY 29 0.0031
690 PROTEINURIA 59 0.0031
691 FLANK PAIN 29 0.0031
692 SKIN HYPERPIGMENTATION 26 0.0030
693 RED BLOOD CELL COUNT DECREASED 86 0.0030
694 SINUS BRADYCARDIA 29 0.0030
695 MIOSIS 24 0.0030
696 MOUTH ULCERATION 63 0.0030
697 SECRETION DISCHARGE 37 0.0030
698 HYPERCALCAEMIA 36 0.0029
699 ANAPHYLACTIC SHOCK 75 0.0029
700 MATERNAL EXPOSURE DURING PREGNANCY 259 0.0029
701 FLUID OVERLOAD 42 0.0029
702 LOWER RESPIRATORY TRACT INFECTION 131 0.0029
703 PULMONARY FIBROSIS 55 0.0029
704 SKIN LESION 77 0.0028
705 APPENDICITIS 26 0.0028
706 ACCIDENT 33 0.0028
707 RENAL INJURY 82 0.0028
708 ATRIAL FLUTTER 22 0.0028
709 FOETAL EXPOSURE DURING PREGNANCY 223 0.0027
710 ANAPHYLACTIC REACTION 151 0.0027
711 LYMPHOMA 42 0.0027
712 CENTRAL NERVOUS SYSTEM LESION 37 0.0027
713 PULMONARY HYPERTENSION 56 0.0027
714 MITRAL VALVE INCOMPETENCE 30 0.0026
715 BLOOD POTASSIUM INCREASED 43 0.0026
716 CARDIOMYOPATHY 39 0.0026
717 BLOOD PRESSURE DECREASED 174 0.0026
718 INFLAMMATION 135 0.0026
719 CONTRAINDICATED PRODUCT ADMINISTERED 79 0.0026
720 DIALYSIS 37 0.0026
721 MUSCLE ATROPHY 33 0.0026
722 HALLUCINATION, VISUAL 54 0.0026
723 SUBDURAL HAEMATOMA 36 0.0025
724 SKIN ULCER 65 0.0025
725 MYASTHENIA GRAVIS 20 0.0025
726 HYPOGLYCAEMIA 120 0.0025
727 CHILLS 290 0.0025
728 LETHARGY 142 0.0025
729 NO THERAPEUTIC RESPONSE 30 0.0025
730 ATAXIA 29 0.0024
731 POLYURIA 20 0.0024
732 TOXICITY TO VARIOUS AGENTS 411 0.0024
733 CHROMATURIA 55 0.0024
734 IMMUNODEFICIENCY 36 0.0024
735 HAEMORRHOIDS 47 0.0024
736 ORAL HERPES 47 0.0024
737 PALLOR 65 0.0024
738 DISEASE RECURRENCE 113 0.0024
739 LIVER FUNCTION TEST INCREASED 51 0.0024
740 DEAFNESS 62 0.0024
741 TOOTH INFECTION 31 0.0023
742 ARTERIOSCLEROSIS 22 0.0023
743 HYPERTENSIVE CRISIS 26 0.0023
744 LUNG DISORDER 113 0.0023
745 URINARY TRACT INFECTION 392 0.0023
746 RENAL DISORDER 107 0.0023
747 PERITONITIS BACTERIAL 23 0.0023
748 NEUROPATHY PERIPHERAL 212 0.0022
749 VENTRICULAR EXTRASYSTOLES 23 0.0022
750 CONFUSIONAL STATE 357 0.0022
751 INTRAOCULAR PRESSURE INCREASED 28 0.0022
752 BLISTER 123 0.0022
753 HAEMATEMESIS 55 0.0022
754 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 152 0.0021
755 ACUTE MYOCARDIAL INFARCTION 62 0.0021
756 JOINT DISLOCATION 22 0.0021
757 DERMATITIS 43 0.0021
758 PULMONARY EMBOLISM 194 0.0020
759 HEPATIC STEATOSIS 38 0.0020
760 HYPOPHAGIA 52 0.0020
761 HEPATIC CIRRHOSIS 38 0.0020
762 BLOOD SODIUM DECREASED 38 0.0020
763 WHEEZING 119 0.0020
764 RASH MACULAR 70 0.0020
765 SKIN REACTION 28 0.0020
766 BLOOD CALCIUM DECREASED 22 0.0020
767 RASH 848 0.0019
768 RASH GENERALISED 50 0.0019
769 DYSPHAGIA 183 0.0019
770 DISORIENTATION 76 0.0019
771 APHASIA 57 0.0019
772 EMPHYSEMA 19 0.0019
773 CONVULSION 107 0.0019
774 MYDRIASIS 24 0.0019
775 REBOUND EFFECT 21 0.0019
776 COVID-19 326 0.0019
777 MUSCLE RIGIDITY 22 0.0018
778 ABDOMINAL PAIN 427 0.0018
779 DIARRHOEA 1174 0.0018
780 STOMATITIS 110 0.0018
781 PAIN IN JAW 51 0.0018
782 BLOOD POTASSIUM DECREASED 54 0.0018
783 THERAPY PARTIAL RESPONDER 28 0.0018
784 ARRHYTHMIA 84 0.0018
785 GINGIVAL BLEEDING 24 0.0018
786 DEEP VEIN THROMBOSIS 114 0.0018
787 GASTRITIS 46 0.0017
788 PRODUCTIVE COUGH 83 0.0017
789 HALLUCINATION 131 0.0017
790 HYPOTHYROIDISM 55 0.0017
791 FAECES DISCOLOURED 37 0.0017
792 IMPAIRED GASTRIC EMPTYING 23 0.0017
793 CONJUNCTIVITIS 31 0.0017
794 UPPER RESPIRATORY TRACT INFECTION 75 0.0016
795 INCORRECT PRODUCT ADMINISTRATION DURATION 35 0.0016
796 PHARYNGITIS 20 0.0016
797 SKIN EXFOLIATION 136 0.0016
798 MALIGNANT NEOPLASM PROGRESSION 165 0.0016
799 NEOPLASM PROGRESSION 56 0.0016
800 GASTRIC ULCER 30 0.0016
801 VOMITING 742 0.0016
802 EPISTAXIS 118 0.0016
803 INTENTIONAL PRODUCT USE ISSUE 136 0.0016
804 RESPIRATORY DEPRESSION 19 0.0015
805 RASH PRURITIC 84 0.0015
806 MENTAL DISORDER 67 0.0015
807 DYSPNOEA 871 0.0015
808 PRODUCT PRESCRIBING ISSUE 33 0.0015
809 ERYTHEMA 311 0.0015
810 DECREASED APPETITE 350 0.0015
811 PSYCHOMOTOR HYPERACTIVITY 25 0.0015
812 RESTLESSNESS 55 0.0015
813 FULL BLOOD COUNT DECREASED 30 0.0015
814 PERICARDITIS 25 0.0015
815 PRODUCT USE ISSUE 272 0.0014
816 OEDEMA PERIPHERAL 176 0.0014
817 HYPERTENSION 305 0.0014
818 SKIN DISORDER 48 0.0014
819 DYSARTHRIA 54 0.0014
820 CHOLELITHIASIS 47 0.0014
821 HAEMATOCHEZIA 79 0.0014
822 INFUSION RELATED REACTION 94 0.0014
823 BLOOD TRIGLYCERIDES INCREASED 25 0.0014
824 DYSURIA 52 0.0014
825 VISUAL ACUITY REDUCED 46 0.0014
826 HERPES ZOSTER 79 0.0014
827 END STAGE RENAL DISEASE 25 0.0014
828 GASTROINTESTINAL DISORDER 122 0.0014
829 PRESCRIBED OVERDOSE 26 0.0013
830 LOSS OF CONSCIOUSNESS 172 0.0013
831 TREATMENT NONCOMPLIANCE 73 0.0013
832 PHOTOSENSITIVITY REACTION 22 0.0013
833 HAEMORRHAGE 138 0.0013
834 PULMONARY ARTERIAL HYPERTENSION 19 0.0013
835 POST PROCEDURAL COMPLICATION 25 0.0013
836 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 38 0.0013
837 DEHYDRATION 173 0.0013
838 ABDOMINAL DISTENSION 132 0.0013
839 ORTHOSTATIC HYPOTENSION 22 0.0013
840 OSTEONECROSIS OF JAW 31 0.0013
841 ISCHAEMIC STROKE 22 0.0012
842 MUSCULAR WEAKNESS 140 0.0012
843 HYPERSENSITIVITY 228 0.0012
844 INTESTINAL OBSTRUCTION 46 0.0012
845 SEDATION 31 0.0012
846 PLASMA CELL MYELOMA 46 0.0012
847 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 20 0.0012
848 AGITATION 85 0.0012
849 URINARY INCONTINENCE 34 0.0011
850 ANGIOEDEMA 50 0.0011
851 DIABETIC KETOACIDOSIS 27 0.0011
852 COUGH 312 0.0011
853 PRURITUS GENERALISED 24 0.0011
854 TINNITUS 50 0.0011
855 TREMOR 180 0.0011
856 THROMBOSIS 87 0.0011
857 CHRONIC KIDNEY DISEASE 81 0.0011
858 CARDIOVASCULAR DISORDER 27 0.0011
859 OVERDOSE 227 0.0011
860 SOMNOLENCE 211 0.0010
861 MUSCLE TWITCHING 24 0.0010
862 IMPAIRED HEALING 34 0.0010
863 PRESYNCOPE 25 0.0010
864 BRONCHITIS 76 0.0010
865 CONSTIPATION 222 0.0010
866 NAUSEA 804 0.0010
867 CHEST PAIN 184 0.0010
868 ACCIDENTAL OVERDOSE 36 0.0010
869 HYPOACUSIS 42 0.0010
870 BACK PAIN 225 0.0010
871 DISTURBANCE IN ATTENTION 52 0.0010
872 DRUG INTOLERANCE 93 0.0010
873 DYSKINESIA 39 0.0010
874 LABORATORY TEST ABNORMAL 28 0.0009
875 SWELLING FACE 61 0.0009
876 RECTAL HAEMORRHAGE 40 0.0009
877 DYSPNOEA EXERTIONAL 35 0.0009
878 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 48 0.0009
879 ASTHENIA 337 0.0009
880 DIABETES MELLITUS 67 0.0009
881 HEART RATE INCREASED 87 0.0009
882 MALAISE 378 0.0009
883 VIRAL INFECTION 28 0.0008
884 NIGHT SWEATS 27 0.0008
885 VERTIGO 51 0.0008
886 SINUSITIS 85 0.0008
887 DEATH 703 0.0008
888 INFLUENZA 91 0.0008
889 BLINDNESS 33 0.0008
890 WEIGHT DECREASED 226 0.0008
891 URINARY RETENTION 27 0.0008
892 NEPHROLITHIASIS 37 0.0008
893 CHEST DISCOMFORT 81 0.0008
894 PRURITUS 303 0.0008
895 CYSTITIS 25 0.0008
896 LIP SWELLING 26 0.0008
897 PALPITATIONS 89 0.0008
898 SYNCOPE 76 0.0008
899 THERAPEUTIC RESPONSE DECREASED 46 0.0008
900 HYPOAESTHESIA 113 0.0008
901 COGNITIVE DISORDER 35 0.0007
902 URTICARIA 120 0.0007
903 WOUND 20 0.0007
904 DYSGEUSIA 52 0.0007
905 DIVERTICULITIS 19 0.0007
906 DYSSTASIA 20 0.0007
907 DYSPHONIA 40 0.0007
908 PSYCHOTIC DISORDER 20 0.0007
909 MOBILITY DECREASED 48 0.0007
910 OROPHARYNGEAL PAIN 61 0.0007
911 THROAT IRRITATION 29 0.0006
912 SWOLLEN TONGUE 20 0.0006
913 ABDOMINAL PAIN UPPER 131 0.0006
914 DYSPEPSIA 62 0.0006
915 SPEECH DISORDER 33 0.0006
916 FLUSHING 64 0.0006
917 PARAESTHESIA 97 0.0006
918 ECZEMA 32 0.0006
919 CARDIAC FAILURE CONGESTIVE 49 0.0006
920 ABNORMAL BEHAVIOUR 24 0.0006
921 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 29 0.0006
922 MYALGIA 102 0.0006
923 MEDICATION ERROR 33 0.0006
924 MOVEMENT DISORDER 19 0.0006
925 PERIPHERAL SWELLING 91 0.0006
926 SKIN DISCOLOURATION 27 0.0006
927 VISUAL IMPAIRMENT 72 0.0006
928 OSTEONECROSIS 19 0.0006
929 SWELLING 54 0.0006
930 INJURY 39 0.0006
931 SYSTEMIC LUPUS ERYTHEMATOSUS 19 0.0005
932 EYE PAIN 30 0.0005
933 FLUID RETENTION 27 0.0005
934 BONE PAIN 30 0.0005
935 RHINORRHOEA 33 0.0005
936 HYPERHIDROSIS 65 0.0005
937 INTENTIONAL PRODUCT MISUSE 44 0.0005
938 NECK PAIN 28 0.0005
939 ASTHMA 56 0.0005
940 CEREBROVASCULAR ACCIDENT 83 0.0005
941 GASTROOESOPHAGEAL REFLUX DISEASE 39 0.0005
942 FATIGUE 376 0.0005
943 PAIN 286 0.0005
944 OSTEOPOROSIS 19 0.0005
945 AGGRESSION 23 0.0005
946 MUSCULOSKELETAL PAIN 24 0.0005
947 HEADACHE 287 0.0005
948 CATARACT 27 0.0005
949 BLOOD PRESSURE INCREASED 69 0.0005
950 PAIN IN EXTREMITY 130 0.0004
951 FLATULENCE 25 0.0004
952 BALANCE DISORDER 38 0.0004
953 WEIGHT INCREASED 98 0.0004
954 ALOPECIA 85 0.0004
955 IRRITABILITY 26 0.0004
956 UNDERDOSE 31 0.0004
957 FALL 141 0.0004
958 INFLUENZA LIKE ILLNESS 34 0.0004
959 INSOMNIA 108 0.0004
960 NO ADVERSE EVENT 73 0.0004
961 ILL-DEFINED DISORDER 24 0.0004
962 THERAPY CESSATION 20 0.0004
963 SLEEP DISORDER 27 0.0004
964 ARTHRALGIA 157 0.0004
965 ADVERSE DRUG REACTION 33 0.0004
966 CARDIAC DISORDER 34 0.0004
967 DISCOMFORT 22 0.0004
968 FEELING HOT 22 0.0004
969 CONTUSION 34 0.0004
970 BLOOD GLUCOSE INCREASED 65 0.0003
971 DEPRESSION 78 0.0003
972 VISION BLURRED 47 0.0003
973 DIZZINESS 170 0.0003
974 HOSPITALISATION 52 0.0003
975 GAIT DISTURBANCE 62 0.0003
976 MUSCULOSKELETAL STIFFNESS 28 0.0003
977 ABDOMINAL DISCOMFORT 53 0.0003
978 INTENTIONAL OVERDOSE 20 0.0003
979 DRUG WITHDRAWAL SYNDROME 27 0.0003
980 MUSCLE SPASMS 55 0.0003
981 MYOCARDIAL INFARCTION 52 0.0003
982 ADVERSE EVENT 27 0.0003
983 HOT FLUSH 22 0.0003
984 ANXIETY 82 0.0003
985 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 49 0.0003
986 SUICIDAL IDEATION 22 0.0002
987 EMOTIONAL DISTRESS 26 0.0002
988 JOINT SWELLING 25 0.0002
989 INCORRECT DOSE ADMINISTERED 45 0.0002
990 FEELING ABNORMAL 44 0.0002
991 NASOPHARYNGITIS 33 0.0002
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 21 0.0001
993 PRODUCT DOSE OMISSION ISSUE 30 0.0001